The Vision Institute is celebrating its 10th anniversary. For the occasion, an international conference will be held from 27 to 29 November 2019 at Sorbonne University. This event is dedicated to new scientific advances as well as therapeutic solutions and will provide a look back on ten years of fight against blindness.
The Vision Institute’s innovative model brings together doctors, industry and researchers from different disciplines from around the world. During these three days, they will be able to exchange ideas and share new ideas about patient needs.
Founded and directed by Professor José-Alain Sahel, the Vision Institute is considered the world's leading vision research center by the French High Evaluation Committee for Research and Science Education.
Under the supervision of Sorbonne University, Inserm and CNRS, this center is part of the "Lifesenses" Laboratory of Excellence, with the objective to bring significant scientific advances in the physiology and pathologies of vision and hearing.
Inaugurated on December 11, 2008, the Institute benefits from an innovative organization that brings together researchers and doctors for the patients of the Quinze Vingts Hospital, which is the French National center for ophthalmology. Twenty academic teams from Sorbonne University, Inserm and CNRS are working on vision diseases and the means of treating them: AMD (age-related macular degeneration), glaucoma, retinopathies pigmentosa and diabetics, artificial retinas, optogenetics, cellular and genetic therapies, retinal imaging, high-throughput screening and others. Important collaborations have been developed, especially with teams from the Paris Observatory, the Pasteur Institut, the Center hospitalier intercommunal of Créteil, the Langevin Institute and the European Institute of Theoretical Neuroscience.
The Vision Institut is also a certified Carnot Institut because of its many industrial partnerships in the field of ophthalmology. This work has led to clinical trials run by start-ups that have been created and housed in the "See & Hear" incubator to bring these therapies directly to patients: through the discovery of new drugs, imaging, surgery and new technologies.
With Sorbonne University, the Quinze-Vingts National Hospital of Ophthalmology, Inserm and Public Assistance - Hospitals of Paris (AP-HP), the Vision Institute supports the project FOReSIGHT. The goal of this project is to accelerate the transfer of therapeutic innovations to patients, thus reducing the harmful impact of vision pathologies. In 2018, the French government awarded funding to only one Hospital-University Institute, the Vision Institute, among the 17 IHU projects that were presented.
Coordinated by the Voir & Entendre (See & Hear) Foundation, the new IHU FOReSIGHT has received 50 million euros in funding over a period of ten years to develop the infrastructure needed to achieve its ambitious goals: the development of therapeutic and diagnostic innovation in ophthalmology; accelerating the transfer of these innovations in the clinical field; assessing the relevance of these innovations for the patient; but also for society, easier access to care; and finally, building an education for all in ophthalmology.